Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
ebi-a-GCST90093329 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFN<U+03B2>-1a subcutaneous and intramuscular) | NA | 1,736 | 7,673,447 |
ebi-a-GCST90093328 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFN<U+03B2>-1a intramuscular) | NA | 591 | 7,730,883 |
ebi-a-GCST90093327 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFN<U+03B2>-1a subcutaneous) | NA | 1,145 | 7,999,650 |
ebi-a-GCST90093110 | 2022 | Type 2 diabetes (adjusted for BMI) | NA | 50,533 | 13,303,236 |
ebi-a-GCST90093109 | 2022 | Type ii diabetes | NA | 50,533 | 13,403,040 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: